Corvus Pharmaceuticals corvuspharma.com


Public list: Pharma Startups (4734) Cancer Therapeutics (1145)

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier investors, the company is well positioned in an exciting new era of immuno-oncology.

Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. With accomplished and talented scientists, and top-tier inves...Show all

Company (IPO / Went public)

Phone: 650-900-4520

Fax:

863 Mitten Road
Suite 102
Burlingame, 94010
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Corvus Pharmaceuticals $179M Mar 23, 2016

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Corvus Pharmaceuticals Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 13 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Anti-cd73 antibodies Jul 11, 2017 Application